The Viscosupplementation Market size is expected to grow at an annual average of 8% during 2021-2027. Viscosupplementation is a medical procedure used for the treatment of osteoarthritis symptoms. It is a non-invasive procedure under which lubricating fluid is injected into joints, which is also referred to as hyaluronic acid injections. It is intended to reduce joint pain and improves the condition of osteoarthritis joints, including knee, hip, ankle, shoulder, spine, wrist, and elbow. A significant rise in the prevalence of osteoarthritis has witnessed over the last decade.
(Get 15% Discount on Buying this Report)
A full report of Viscosupplementation Market is available at: https://www.orionmarketreports.com/viscosupplementation-market/11132/
The following segmentation are covered in this report:
Product Outlook
- Single Injection
- Three Injection
- Five Injection
End-Use Outlook
- Hospitals
- Orthopedic Clinic/ Ambulatory Surgical Centers (ASCs)
Company Profile
- Sanofi
- Anika Therapeutics, Inc.
- Seikagaku Corporation
- Zimmer Biomet
- Ferring B.V.
- LG Chem
- Chugai Pharmaceutical Co., Ltd,
- Bioventus, Inc.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Viscosupplementation Market
- The market share of the global Viscosupplementation Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Viscosupplementation Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Viscosupplementation Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
